Odyssey Therapeutics, Inc. (ODTX) vs QuidelOrtho Corporation (QDEL)
A side-by-side comparison of Odyssey Therapeutics, Inc. and QuidelOrtho Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ODTX
Odyssey Therapeutics, Inc.
$18.27HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
QDEL
QuidelOrtho Corporation
$12.46HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — ODTX vs QDEL
growth of $100 · dividends reinvested · last 1yODTX +26.9% (+26.9%/yr)QDEL +4.1% (+4.1%/yr)ODTX compounded faster over this window
ODTX QDEL
ODTX vs QDEL: by the numbers
- •ODTX is the larger company ($878M vs $850M market cap).
- •Both run net losses; QDEL's is the smaller (-39.20% vs -4994.86% net margin).
Metrics side by side
Valuation
| Metric | ODTX | QDEL |
|---|---|---|
| Forward P/E | N/A | 16.13 |
| P/S ratio | N/A | 0.32 |
| P/B ratio | 2.08 | 0.48 |
Profitability
| Metric | ODTX | QDEL |
|---|---|---|
| Gross margin | 100.00% | 44.60% |
| Operating margin | -5415.19% | -30.67% |
| Net margin | -4994.86% | -39.20% |
| ROE | N/A | -59.07% |
| ROIC | -66.23% | -16.05% |
Growth (annualized)
| Metric | ODTX | QDEL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.14% |
| Total return CAGR (5Y) | N/A | -38.12% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.